Ticker Details
Bio-Rad Laboratories, Inc.Class A Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$7.7B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$10.25 | 1.14%
Avg Daily Range (30 D):	$4.03 | 1.45%
Avg Daily Range (90 D):	$3.92 | 1.40%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	21

Institutional Trades
Total Institutional Trades:	4,407
Avg Institutional Trade:	$9.19M
Avg Institutional Trade (30 D):	$14.44M
Avg Institutional Trade (90 D):	$13.29M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$11.52M
Avg Closing Trade (30 D):	$20.05M
Avg Closing Trade (90 D):	$16.53M
Avg Closing Volume:	33.84K

News

May 18, 2026 @ 6:34 PM Why Elliott Sees Hidden Billions Inside Bio-Rad La... Source: Vandana Singh

May 18, 2026 @ 5:12 PM Nvidia Earnings Could Decide Whether the AI Trade ... Source: Itai Smidt

May 14, 2026 @ 7:37 AM Cancer Biomarkers Market Outlook 2026–2031:... Source: Mordor Intelligence

May 6, 2026 @ 5:00 PM Global DNA Microarray Market is Predicted to Exhib... Source: Delveinsight

May 4, 2026 @ 7:30 PM [Latest] Global Targeted DNA RNA Sequencing Market... Source: Healthcare Foresights

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$27.87		$27.87
Diluted EPS	$27.85		$27.85
Revenue	$2.58B		$2.58B
Gross Profit	$1.34B		$1.34B
Net Income / Loss	$759.9M		$759.9M
Operating Income / Loss	$47.2M		$47.2M
Cost of Revenue	$1.24B		$1.24B
Net Cash Flow	$59.3M		$59.3M
PE Ratio

Splits
Mar 08, 2002	2:1